SCHEMBL27597047

SCHEMBL27597047

Cc1nc(NC(N)=O)sc1-c1ccc(S(C)(=O)=O)cc1

nearest known ligand 0.81

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 13/20 0.81
PIK3CG P48736 13/20 0.81
PIK3CD O00329 12/20 0.81
PIK3CB P42338 9/20 0.81
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
XIAP P98170 1/20 0.51
AOC3 Q16853 2/20 0.50
NPC1 O15118 1/20 0.45
CASP3 P42574 1/20 0.45
RAB9A P51151 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
ATR Q13535 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL48857 0.89 PIK3CG (1.00) PIK3CAPIK3CGPIK3CDPIK3CBAOC3
SCHEMBL48623 0.84 PIK3CD (0.72) PIK3CAPIK3CGPIK3CDPIK3CBXIAP
SCHEMBL1786144 0.82 PIK3CD (0.66) PIK3CAPIK3CGPIK3CDPIK3CBMEN1
SCHEMBL1786138 0.82 PIK3CD (0.66) PIK3CAPIK3CGPIK3CDPIK3CBMEN1
SCHEMBL48850 0.82 PIK3CD (0.69) PIK3CAPIK3CGPIK3CDPIK3CBMEN1
SCHEMBL48762 0.82 PIK3CD (0.67) PIK3CAPIK3CGPIK3CDPIK3CB
SCHEMBL1784577 0.82 PIK3CD (0.69) PIK3CAPIK3CGPIK3CDPIK3CB
SCHEMBL48835 0.82 PIK3CD (0.81) PIK3CAPIK3CGPIK3CDPIK3CBXIAP
SCHEMBL27656677 0.80 PIK3CG (0.56) PIK3CAPIK3CGPIK3CDPIK3CBMEN1
SCHEMBL48391 0.80 PIK3CG (1.00) PIK3CAPIK3CGPIK3CDPIK3CBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100548996-C 5-phenylthiazole derivatives and their use for the preparation of medicaments NOVARTIS AG (CH) 2009-10-14 CN disclosed
CN-1639139-A 5-phenylthiazole derivatives and use as PI3 kinase inhibitors NOVARTIS AG (CH) 2005-07-13 CN disclosed